Pace of Hospital Lab Acquisitions Likely to Remain Steady
Learn more about the steady pace of laboratory acquisitions and what factors are likely to increase or decrease this trend.
CareTinumm Advisors Founder & Managing Partner, Keith Laughman recently shared thoughts on the pace of hospital laboratory acquisitions with 360DX. Read the full article to learn more about the steady pace of laboratory acquisitions and what factors are likely to increase or decrease this trend.
Keith Laughman has more than 30 years’ experience in the lab business, including a 15-year term as President of Mayo Medical Labs. Following Mayo, Laughman became President of AmeriPath Reference Services and Specialty Reference Laboratories. He later helped to create and served as President and CEO of the reference lab startup Med Fusion (Dallas/Fort Worth). Both AmeriPath and Med Fusion were later sold to Quest Diagnostics. Most recently, Laughman serves as the Managing Partner at CareTinuum Advisors.
Latest posts by Keith Laughman (see all)
- Labacoeconomics™: Expanding the Role of Clinical Laboratories in Value-Based Healthcare - February 26, 2024
- Pace of Hospital Lab Acquisitions Likely to Remain Steady - April 29, 2023
- Measuring Clinical Laboratory Contributions - April 29, 2023